Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2).


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
04 2021
Historique:
received: 21 04 2020
accepted: 17 10 2020
pubmed: 12 11 2020
medline: 17 4 2021
entrez: 11 11 2020
Statut: ppublish

Résumé

To determine clinical, pathological and virological factors predicting the spontaneous regression of HSIL/CIN2. This retrospective study included 73 patients with HSIL/CIN2 diagnosed by biopsy between 2012 and 2016 and followed-up without treatment in the department of gynecology at Bordeaux University Hospital. All biopsies sampled inside or outside our department were reviewed and immunolabelled for p16 and Ki67. The response rate was the regression or the disappearance of HSIL/CIN2 as defined by the regression or the disappearance of initial colposcopic findings, cytological and/or histological results. The diagnosis of CIN2 was confirmed in 63 of 70 biopsies available for review. The Cohen's kappa coefficient was κ = 90%, indicating almost perfect inter-observer agreement. The lesion spontaneously regressed or disappeared in 36 of 60 patients (60%) with confirmed CIN2 during a median follow-up of 20 months (range 6-55). Baseline factors influencing the response rate were colposcopic findings (69% with minor change vs 31% with major change, p = 0.033), cytological results (72% with ASCUS/LSIL vs 28% with ASC-H/HSIL, p = 0.018), and HPV genotyping (71% with HPV not 16 vs 42% with HPV-16, p = 0.027). The other factors (age, smoking, surface area of the lesion, p16 and Ki67 expressions) did not significantly influence the outcome. Colposcopic findings, cytological results, and HPV genotyping were baseline factors predicting spontaneous regression of HSIL/CIN2.

Identifiants

pubmed: 33175197
doi: 10.1007/s00404-020-05853-3
pii: 10.1007/s00404-020-05853-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1065-1073

Références

Stoler M, Bergeron C, Colgan TJ, Ferenczy A, Herrington CS, Loening T et al (2014) Tumours of the uterine cervix. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs. Lyon, France, IARC and WHO, pp 169–206
Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas-Hernándes J, Glazer-Livson S et al (2018) Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 360:k499
doi: 10.1136/bmj.k499
Zhang J, Lu CX (2019) Spontaneous regression of cervical intraepithelial neoplasia 2: a meta-analysis. Gynecol Obstet Invest 84:62–67
Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P et al (2016) Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ 354:i3633
doi: 10.1136/bmj.i3633
El-Nashar SA, Shazly SA, Hopkins MR, Bakkum-Gamez JN, Famuyide AO (2017) Loop electrosurgical excision procedure instead of cold-knife conization for cervical intraepithelial neoplasia in women with unsatisfactory colposcopic examinations: a systematic review and meta-analysis. J Low Genit Tract Dis 21:129–136
doi: 10.1097/LGT.0000000000000287
Tanaka Y, Ueda Y, Kakuda M, Kubota S, Matsuzaki S, Iwamiya T et al (2017) Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases. Int J Clin Oncol 22:921–926
doi: 10.1007/s10147-017-1124-z
Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355
doi: 10.1016/j.ajog.2007.07.047
Macdonald M, Smith JHF, Tidy JA, Palmer JE (2018) Conservative management of CIN2: national Audit of British Society for Colposcopy and Cervical Pathology members’ opinion. J Obstet Gynaecol 38:388–394
doi: 10.1080/01443615.2017.1316973
French National Cancer Institute (INCa) (2016) Management of women with abnormal cervical cytology. https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Summary-Management-of-women-with-abnormal-cervical-cytology , Accessed 25 March 2020
Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M et al (2012) 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 120:166–172
doi: 10.1097/AOG.0b013e318254f90c
Nayar R, Wilbur DC (2015) The pap test and Bethesda 2014. Acta Cytol 59:121–132
doi: 10.1159/000381842
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100(Pt B): 1–441
Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD et al (2012) The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Lower Genit Tract Dis 16:205–242
doi: 10.1097/LGT.0b013e31825c31dd
Robertson AJ, Anderson JM, Beck JS, Burnett RA, Howatson SR, Lee FD et al (1989) Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 42:231–238
doi: 10.1136/jcp.42.3.231
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P et al (2009) p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 35:210–220
doi: 10.1016/j.ctrv.2008.10.005
Fan A, Wang C, Zhang L, Yan Y, Han C, Xue F (2018) Diagnostic value of the 2011 International Federation for Cervical Pathology and Colposcopy Terminology in predicting cervical lesions. Oncotarget 9:9166–9176
doi: 10.18632/oncotarget.24074
Discacciati MG, de Souza CA, d’Otavianno MG, Ângelo-Andrade LA, Westin MC, Rabelo-Santos SH et al (2011) Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months. Eur J Obstet Gynecol Reprod Biol 155:204–208
doi: 10.1016/j.ejogrb.2010.12.002
Castle PE, Schiffman M, Wheeler CM, Solomon D (2009) Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 113:18–25
doi: 10.1097/AOG.0b013e31818f5008
Ho GY, Einstein MH, Romney SL, Kadish AS, Abadi M, Mikhail M et al (2011) Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2 managed by watchful waiting. J Low Genit Tract Dis 15:268–275
doi: 10.1097/LGT.0b013e3182216fef
Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K et al (2014) Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2. J Obstet Gynaecol Res 40:561–569
doi: 10.1111/jog.12202
Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A et al (2005) Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 11:4717–4723
doi: 10.1158/1078-0432.CCR-04-2599
Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S et al (2010) Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 116(6):1373
doi: 10.1097/AOG.0b013e3181fe777f
Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B et al (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 132:854–867
doi: 10.1002/ijc.27713
Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B et al (2017) ASCCP colposcopy standards: how do we perform colposcopy? Implications for establishing standards. J Low Genit Tract Dis 21:235–241
doi: 10.1097/LGT.0000000000000336

Auteurs

Jean-Luc Brun (JL)

Department of Gynecology, University Hospital of Bordeaux, Place Amélie Raba Leon, 33076, Bordeaux, France. jean-luc.brun@chu-bordeaux.fr.
UMR 5234, Microbiology and Pathogenicity, University Hospital of Bordeaux, Bordeaux, France. jean-luc.brun@chu-bordeaux.fr.

Déborah Letoffet (D)

Department of Pathology, University Hospital of Bordeaux, Bordeaux, France.

Marion Marty (M)

Department of Pathology, University Hospital of Bordeaux, Bordeaux, France.

Romain Griffier (R)

Department of Public Health, University Hospital of Bordeaux, Bordeaux, France.

Xavier Ah-Kit (X)

Department of Gynecology, University Hospital of Bordeaux, Place Amélie Raba Leon, 33076, Bordeaux, France.

Isabelle Garrigue (I)

UMR 5234, Microbiology and Pathogenicity, University Hospital of Bordeaux, Bordeaux, France.
Laboratory of Virology, University Hospital of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH